Back to calendar
Estrella Immunopharma, Inc. (ESLA) Earnings
ESLA reports earnings on Wednesday, December 2, 2026
earnings report
December 2, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.08
Actual EPS: $-0.05
EPS surprise: 0.00%
Company overview
Market Cap$19.3M
PriceUSD 0.44
EPS (TTM)-0.25
52-week high3.01
52-week low0.24
SectorHealth Technology
IndustryBiotechnology